Philip Reigan
Concepts (395)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antineoplastic Agents | 17 | 2025 | 2053 | 2.410 |
Why?
| Thymidine Phosphorylase | 7 | 2022 | 14 | 2.370 |
Why?
| Ribosomal Protein S6 Kinases, 90-kDa | 4 | 2021 | 12 | 1.980 |
Why?
| Protein Kinase Inhibitors | 9 | 2025 | 890 | 1.940 |
Why?
| Pyrimidines | 6 | 2021 | 459 | 1.700 |
Why?
| Protein-Tyrosine Kinases | 6 | 2019 | 432 | 1.550 |
Why?
| AMP-Activated Protein Kinases | 2 | 2025 | 191 | 1.450 |
Why?
| Cell Cycle Proteins | 5 | 2018 | 584 | 1.400 |
Why?
| Nuclear Proteins | 6 | 2018 | 659 | 1.390 |
Why?
| Neoplasms | 6 | 2025 | 2449 | 1.260 |
Why?
| Enzyme Inhibitors | 9 | 2021 | 827 | 1.240 |
Why?
| STAT3 Transcription Factor | 3 | 2022 | 194 | 1.080 |
Why?
| Glioblastoma | 3 | 2022 | 322 | 1.060 |
Why?
| Pyrazoles | 4 | 2018 | 404 | 0.970 |
Why?
| Models, Molecular | 25 | 2021 | 1486 | 0.950 |
Why?
| Pyrroles | 2 | 2021 | 202 | 0.880 |
Why?
| Small Molecule Libraries | 3 | 2025 | 86 | 0.840 |
Why?
| Prodrugs | 4 | 2007 | 48 | 0.790 |
Why?
| Drug Resistance, Neoplasm | 5 | 2025 | 756 | 0.780 |
Why?
| NAD(P)H Dehydrogenase (Quinone) | 8 | 2011 | 32 | 0.740 |
Why?
| Pyrimidinones | 4 | 2018 | 103 | 0.730 |
Why?
| Purines | 1 | 2021 | 172 | 0.670 |
Why?
| Pteridines | 1 | 2020 | 20 | 0.660 |
Why?
| Cell Survival | 8 | 2022 | 1074 | 0.640 |
Why?
| Structure-Activity Relationship | 10 | 2020 | 543 | 0.630 |
Why?
| Indolequinones | 5 | 2011 | 5 | 0.610 |
Why?
| Aldehydes | 8 | 2014 | 142 | 0.570 |
Why?
| HSP90 Heat-Shock Proteins | 5 | 2011 | 45 | 0.560 |
Why?
| Protein Binding | 12 | 2021 | 2120 | 0.540 |
Why?
| Medulloblastoma | 2 | 2016 | 192 | 0.520 |
Why?
| Brain Neoplasms | 3 | 2020 | 1143 | 0.520 |
Why?
| Glutamate-Cysteine Ligase | 2 | 2013 | 18 | 0.520 |
Why?
| Xanthine Oxidase | 2 | 2007 | 78 | 0.500 |
Why?
| Cell Line, Tumor | 18 | 2022 | 3201 | 0.500 |
Why?
| Benzoquinones | 4 | 2011 | 48 | 0.490 |
Why?
| Protein Isoforms | 1 | 2017 | 389 | 0.480 |
Why?
| Uracil | 3 | 2021 | 30 | 0.470 |
Why?
| Isoxazoles | 5 | 2023 | 55 | 0.450 |
Why?
| Hydroquinones | 3 | 2011 | 29 | 0.440 |
Why?
| Cisplatin | 1 | 2016 | 299 | 0.430 |
Why?
| Lactams, Macrocyclic | 3 | 2011 | 49 | 0.430 |
Why?
| Deoxyribose | 1 | 2013 | 6 | 0.430 |
Why?
| Drug Screening Assays, Antitumor | 5 | 2020 | 192 | 0.410 |
Why?
| Glutathione | 2 | 2011 | 347 | 0.400 |
Why?
| Humans | 58 | 2025 | 129248 | 0.370 |
Why?
| Molecular Structure | 5 | 2020 | 478 | 0.360 |
Why?
| Molecular Docking Simulation | 6 | 2023 | 108 | 0.350 |
Why?
| Protein Conformation | 4 | 2021 | 861 | 0.320 |
Why?
| Catalytic Domain | 5 | 2021 | 218 | 0.320 |
Why?
| Cell Line | 5 | 2022 | 2779 | 0.310 |
Why?
| Cell Proliferation | 10 | 2020 | 2374 | 0.310 |
Why?
| Glucose | 2 | 2013 | 1001 | 0.300 |
Why?
| Imidazoles | 3 | 2021 | 234 | 0.300 |
Why?
| Aldehyde Dehydrogenase | 3 | 2014 | 101 | 0.300 |
Why?
| Molecular Targeted Therapy | 3 | 2016 | 390 | 0.290 |
Why?
| Proto-Oncogene Proteins B-raf | 2 | 2021 | 209 | 0.290 |
Why?
| Animals | 29 | 2025 | 35307 | 0.280 |
Why?
| Amides | 2 | 2020 | 91 | 0.280 |
Why?
| Growth Inhibitors | 1 | 2007 | 44 | 0.280 |
Why?
| Signal Transduction | 6 | 2022 | 4926 | 0.270 |
Why?
| Proto-Oncogene Proteins c-akt | 4 | 2013 | 431 | 0.260 |
Why?
| src Homology Domains | 2 | 2016 | 37 | 0.260 |
Why?
| Thyroid Neoplasms | 2 | 2021 | 310 | 0.250 |
Why?
| Pancreatic Neoplasms | 4 | 2009 | 881 | 0.250 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2023 | 509 | 0.240 |
Why?
| Binding Sites | 6 | 2018 | 1249 | 0.230 |
Why?
| Molecular Dynamics Simulation | 3 | 2023 | 217 | 0.230 |
Why?
| Rotenone | 1 | 2024 | 10 | 0.230 |
Why?
| Pyrrolidines | 1 | 2004 | 67 | 0.230 |
Why?
| G-Quadruplexes | 2 | 2022 | 17 | 0.220 |
Why?
| alpha-Synuclein | 1 | 2024 | 31 | 0.220 |
Why?
| Giardia lamblia | 1 | 2024 | 23 | 0.220 |
Why?
| Dopaminergic Neurons | 1 | 2024 | 57 | 0.220 |
Why?
| Thymidine | 2 | 2022 | 59 | 0.210 |
Why?
| Neuroprotective Agents | 1 | 2024 | 122 | 0.210 |
Why?
| Rifabutin | 3 | 2008 | 6 | 0.200 |
Why?
| Polycomb Repressive Complex 1 | 1 | 2023 | 48 | 0.200 |
Why?
| Receptors, Glucocorticoid | 1 | 2024 | 148 | 0.200 |
Why?
| DNA | 3 | 2016 | 1396 | 0.200 |
Why?
| Tumor Microenvironment | 2 | 2025 | 631 | 0.200 |
Why?
| Liver Diseases, Alcoholic | 2 | 2014 | 89 | 0.200 |
Why?
| Ear Diseases | 1 | 2022 | 14 | 0.190 |
Why?
| Amino Acid Transport System ASC | 1 | 2022 | 12 | 0.190 |
Why?
| K562 Cells | 2 | 2020 | 86 | 0.190 |
Why?
| Virus Internalization | 1 | 2022 | 47 | 0.190 |
Why?
| Models, Chemical | 1 | 2023 | 262 | 0.190 |
Why?
| Minor Histocompatibility Antigens | 1 | 2022 | 46 | 0.190 |
Why?
| Catalysis | 3 | 2013 | 307 | 0.180 |
Why?
| Drug Synergism | 3 | 2021 | 370 | 0.180 |
Why?
| Quinone Reductases | 2 | 2011 | 17 | 0.180 |
Why?
| Fluorouracil | 1 | 2022 | 198 | 0.180 |
Why?
| Mice | 18 | 2024 | 16915 | 0.180 |
Why?
| Maneb | 1 | 2020 | 9 | 0.180 |
Why?
| Proto-Oncogene Proteins c-myc | 1 | 2022 | 131 | 0.180 |
Why?
| Receptors, Androgen | 1 | 2022 | 147 | 0.170 |
Why?
| Heterocyclic Compounds | 1 | 2020 | 18 | 0.170 |
Why?
| Lipoprotein Lipase | 1 | 2020 | 59 | 0.170 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 151 | 0.170 |
Why?
| Dose-Response Relationship, Drug | 3 | 2020 | 2008 | 0.170 |
Why?
| Fluorescence | 1 | 2020 | 155 | 0.170 |
Why?
| Polymorphism, Genetic | 2 | 2014 | 639 | 0.170 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2021 | 184 | 0.170 |
Why?
| Neovascularization, Pathologic | 1 | 2022 | 296 | 0.170 |
Why?
| Mice, Inbred C57BL | 5 | 2024 | 5439 | 0.160 |
Why?
| Amino Acid Sequence | 8 | 2014 | 2056 | 0.160 |
Why?
| Adenocarcinoma, Follicular | 1 | 2019 | 34 | 0.150 |
Why?
| Thyroid Carcinoma, Anaplastic | 1 | 2019 | 35 | 0.150 |
Why?
| Protein Carbonylation | 3 | 2013 | 56 | 0.150 |
Why?
| Enzyme Assays | 1 | 2018 | 25 | 0.150 |
Why?
| CDC2 Protein Kinase | 1 | 2018 | 31 | 0.150 |
Why?
| Chromatography, High Pressure Liquid | 5 | 2013 | 580 | 0.150 |
Why?
| Pyridazines | 1 | 2018 | 54 | 0.150 |
Why?
| Receptors, Metabotropic Glutamate | 1 | 2018 | 41 | 0.150 |
Why?
| Escherichia coli | 4 | 2006 | 766 | 0.140 |
Why?
| Neoplastic Stem Cells | 1 | 2022 | 379 | 0.140 |
Why?
| Phosphorylation | 3 | 2018 | 1710 | 0.140 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 259 | 0.140 |
Why?
| Glucocorticoids | 1 | 2022 | 578 | 0.140 |
Why?
| Dihydropyridines | 1 | 2017 | 15 | 0.140 |
Why?
| Cyclic S-Oxides | 1 | 2016 | 1 | 0.140 |
Why?
| Niclosamide | 1 | 2016 | 2 | 0.140 |
Why?
| Leukemia, Myeloid, Acute | 2 | 2022 | 592 | 0.140 |
Why?
| Oncogene Proteins, Fusion | 1 | 2019 | 200 | 0.140 |
Why?
| Glycoproteins | 2 | 2011 | 338 | 0.140 |
Why?
| Fluorescence Polarization | 1 | 2016 | 38 | 0.130 |
Why?
| Antigens, Neoplasm | 2 | 2011 | 308 | 0.130 |
Why?
| Antioxidants | 2 | 2011 | 558 | 0.130 |
Why?
| G2 Phase Cell Cycle Checkpoints | 1 | 2016 | 45 | 0.130 |
Why?
| M Phase Cell Cycle Checkpoints | 1 | 2016 | 24 | 0.130 |
Why?
| Lysine | 2 | 2023 | 286 | 0.130 |
Why?
| MicroRNAs | 1 | 2023 | 676 | 0.130 |
Why?
| Molecular Sequence Data | 7 | 2014 | 2835 | 0.130 |
Why?
| Quantitative Structure-Activity Relationship | 1 | 2015 | 14 | 0.130 |
Why?
| Antiviral Agents | 1 | 2022 | 712 | 0.130 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2013 | 136 | 0.130 |
Why?
| Immunity, Innate | 1 | 2022 | 803 | 0.130 |
Why?
| Crystallography, X-Ray | 5 | 2017 | 435 | 0.120 |
Why?
| Drug Design | 1 | 2016 | 156 | 0.120 |
Why?
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2015 | 10 | 0.120 |
Why?
| Cells, Cultured | 3 | 2020 | 4076 | 0.120 |
Why?
| Oxidation-Reduction | 5 | 2020 | 1028 | 0.120 |
Why?
| Retinaldehyde | 1 | 2014 | 5 | 0.120 |
Why?
| HeLa Cells | 1 | 2016 | 611 | 0.120 |
Why?
| Parkinson Disease | 1 | 2020 | 461 | 0.120 |
Why?
| Allosteric Regulation | 3 | 2023 | 99 | 0.120 |
Why?
| Acetaldehyde | 1 | 2014 | 17 | 0.120 |
Why?
| Drug Discovery | 1 | 2016 | 131 | 0.120 |
Why?
| Alzheimer Disease | 1 | 2020 | 514 | 0.120 |
Why?
| Recombinant Proteins | 5 | 2011 | 1304 | 0.120 |
Why?
| Membrane Proteins | 2 | 2011 | 1117 | 0.120 |
Why?
| Sulfhydryl Compounds | 2 | 2020 | 187 | 0.120 |
Why?
| DNA Repair | 1 | 2016 | 206 | 0.120 |
Why?
| Mass Spectrometry | 4 | 2012 | 713 | 0.110 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 833 | 0.110 |
Why?
| Pituitary Neoplasms | 1 | 2015 | 179 | 0.110 |
Why?
| Computer Simulation | 4 | 2014 | 939 | 0.110 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2014 | 101 | 0.110 |
Why?
| Fatty Liver, Alcoholic | 1 | 2013 | 15 | 0.110 |
Why?
| Heat-Shock Proteins | 1 | 2014 | 136 | 0.110 |
Why?
| Mammary Glands, Animal | 2 | 2011 | 120 | 0.110 |
Why?
| Protein Folding | 2 | 2014 | 264 | 0.110 |
Why?
| Adenosine Triphosphatases | 1 | 2014 | 161 | 0.110 |
Why?
| Antimetabolites, Antineoplastic | 1 | 2013 | 91 | 0.100 |
Why?
| Lactation | 2 | 2011 | 169 | 0.100 |
Why?
| Hypoxanthine Phosphoribosyltransferase | 1 | 2013 | 25 | 0.100 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2014 | 169 | 0.100 |
Why?
| Inflammation | 2 | 2022 | 2737 | 0.100 |
Why?
| Cell Cycle | 2 | 2014 | 589 | 0.100 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 327 | 0.100 |
Why?
| Gout | 1 | 2013 | 33 | 0.100 |
Why?
| Gene Expression Regulation | 3 | 2013 | 2537 | 0.100 |
Why?
| Electron Transport Complex I | 1 | 2012 | 39 | 0.100 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1555 | 0.100 |
Why?
| Status Epilepticus | 1 | 2012 | 42 | 0.100 |
Why?
| PTEN Phosphohydrolase | 1 | 2013 | 161 | 0.100 |
Why?
| Acridines | 1 | 2011 | 7 | 0.100 |
Why?
| Fatty Acid-Binding Proteins | 1 | 2012 | 68 | 0.100 |
Why?
| Glutathione Reductase | 1 | 2011 | 24 | 0.100 |
Why?
| Apoptosis | 6 | 2021 | 2498 | 0.100 |
Why?
| Glutathione Peroxidase | 1 | 2011 | 43 | 0.090 |
Why?
| DNA Topoisomerases, Type II | 1 | 2011 | 43 | 0.090 |
Why?
| Glutathione Transferase | 1 | 2011 | 102 | 0.090 |
Why?
| Flavoproteins | 1 | 2011 | 8 | 0.090 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 217 | 0.090 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 442 | 0.090 |
Why?
| Transcriptional Activation | 1 | 2013 | 367 | 0.090 |
Why?
| Glycolipids | 1 | 2011 | 42 | 0.090 |
Why?
| Organelles | 1 | 2011 | 54 | 0.090 |
Why?
| Mitochondria, Liver | 1 | 2011 | 74 | 0.090 |
Why?
| Myocytes, Cardiac | 1 | 2015 | 499 | 0.090 |
Why?
| Xenograft Model Antitumor Assays | 4 | 2021 | 812 | 0.090 |
Why?
| Hydrogen Peroxide | 1 | 2012 | 317 | 0.090 |
Why?
| Sirtuin 3 | 1 | 2011 | 58 | 0.090 |
Why?
| Milk | 1 | 2011 | 119 | 0.080 |
Why?
| Enzyme Activation | 2 | 2013 | 812 | 0.080 |
Why?
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 124 | 0.080 |
Why?
| Superoxide Dismutase | 1 | 2012 | 342 | 0.080 |
Why?
| Indoles | 2 | 2015 | 384 | 0.080 |
Why?
| Brain | 2 | 2012 | 2669 | 0.080 |
Why?
| Carcinoma, Hepatocellular | 1 | 2012 | 272 | 0.080 |
Why?
| Protein Processing, Post-Translational | 1 | 2012 | 454 | 0.080 |
Why?
| Kinetics | 1 | 2013 | 1644 | 0.080 |
Why?
| Breast Neoplasms | 2 | 2020 | 2140 | 0.080 |
Why?
| Cell Movement | 1 | 2014 | 944 | 0.080 |
Why?
| Phospholipids | 1 | 2011 | 215 | 0.080 |
Why?
| Oxidative Stress | 2 | 2014 | 1265 | 0.080 |
Why?
| Thioredoxin-Disulfide Reductase | 1 | 2009 | 13 | 0.080 |
Why?
| Adenosine Triphosphate | 1 | 2011 | 478 | 0.080 |
Why?
| Peroxiredoxin VI | 1 | 2008 | 5 | 0.080 |
Why?
| Protein Structure, Tertiary | 4 | 2014 | 841 | 0.080 |
Why?
| Tumor Cells, Cultured | 3 | 2022 | 942 | 0.080 |
Why?
| Disease Models, Animal | 4 | 2024 | 4057 | 0.080 |
Why?
| Down-Regulation | 1 | 2011 | 636 | 0.080 |
Why?
| Protein Interaction Domains and Motifs | 3 | 2013 | 138 | 0.070 |
Why?
| Cross-Linking Reagents | 1 | 2008 | 205 | 0.070 |
Why?
| Quinones | 1 | 2007 | 9 | 0.070 |
Why?
| Lipid Metabolism | 1 | 2011 | 497 | 0.070 |
Why?
| DNA-Binding Proteins | 2 | 2013 | 1446 | 0.070 |
Why?
| Mutation | 4 | 2021 | 3710 | 0.070 |
Why?
| Spectrophotometry, Infrared | 1 | 2007 | 54 | 0.070 |
Why?
| NF-kappa B p50 Subunit | 1 | 2007 | 24 | 0.070 |
Why?
| Acrolein | 1 | 2007 | 23 | 0.070 |
Why?
| Cell Membrane | 1 | 2011 | 732 | 0.070 |
Why?
| Galactosides | 1 | 2006 | 4 | 0.070 |
Why?
| beta-Galactosidase | 1 | 2006 | 77 | 0.070 |
Why?
| Energy Metabolism | 1 | 2012 | 873 | 0.060 |
Why?
| Anti-Bacterial Agents | 2 | 2024 | 1702 | 0.060 |
Why?
| Substrate Specificity | 3 | 2014 | 368 | 0.060 |
Why?
| RNA, Messenger | 2 | 2024 | 2703 | 0.060 |
Why?
| Arginine | 3 | 2013 | 265 | 0.060 |
Why?
| Carcinoma | 1 | 2007 | 215 | 0.060 |
Why?
| Nitroimidazoles | 1 | 2005 | 9 | 0.060 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2007 | 537 | 0.060 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 3 | 2011 | 179 | 0.060 |
Why?
| Biological Availability | 1 | 2005 | 147 | 0.060 |
Why?
| Phenanthrenes | 1 | 2024 | 12 | 0.060 |
Why?
| Computational Biology | 1 | 2008 | 595 | 0.060 |
Why?
| Emetine | 1 | 2024 | 6 | 0.060 |
Why?
| Parkinsonian Disorders | 1 | 2024 | 35 | 0.060 |
Why?
| Aldehyde Dehydrogenase, Mitochondrial | 2 | 2014 | 23 | 0.060 |
Why?
| Substantia Nigra | 1 | 2024 | 56 | 0.060 |
Why?
| Mice, Nude | 2 | 2021 | 682 | 0.050 |
Why?
| Polycomb-Group Proteins | 1 | 2023 | 28 | 0.050 |
Why?
| Cryoelectron Microscopy | 1 | 2024 | 177 | 0.050 |
Why?
| Peptides | 2 | 2023 | 923 | 0.050 |
Why?
| Benzamides | 1 | 2023 | 207 | 0.050 |
Why?
| Insulin Resistance | 1 | 2011 | 1165 | 0.050 |
Why?
| Exoribonucleases | 1 | 2023 | 43 | 0.050 |
Why?
| Ribosomes | 1 | 2024 | 164 | 0.050 |
Why?
| Molecular Conformation | 2 | 2015 | 141 | 0.050 |
Why?
| Alcohols | 1 | 2022 | 29 | 0.050 |
Why?
| Phospholipase C beta | 1 | 2022 | 30 | 0.050 |
Why?
| Stress, Physiological | 2 | 2015 | 414 | 0.050 |
Why?
| Mesocricetus | 1 | 2022 | 37 | 0.050 |
Why?
| Hep G2 Cells | 2 | 2013 | 61 | 0.050 |
Why?
| Ear | 1 | 2022 | 31 | 0.050 |
Why?
| Ethanol | 3 | 2012 | 589 | 0.050 |
Why?
| Peptide Mapping | 2 | 2012 | 63 | 0.050 |
Why?
| High-Throughput Screening Assays | 1 | 2023 | 138 | 0.050 |
Why?
| Sequence Alignment | 2 | 2012 | 332 | 0.050 |
Why?
| Serine Endopeptidases | 1 | 2022 | 118 | 0.050 |
Why?
| Oximes | 1 | 2021 | 22 | 0.050 |
Why?
| Perilipin-2 | 2 | 2011 | 36 | 0.050 |
Why?
| Angiogenesis Inhibitors | 1 | 2003 | 220 | 0.050 |
Why?
| Neural Crest | 1 | 2022 | 114 | 0.040 |
Why?
| Oxidative Phosphorylation | 1 | 2022 | 187 | 0.040 |
Why?
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 108 | 0.040 |
Why?
| Indazoles | 1 | 2021 | 66 | 0.040 |
Why?
| Cell-Free System | 2 | 2011 | 48 | 0.040 |
Why?
| Blotting, Western | 2 | 2013 | 1204 | 0.040 |
Why?
| Viral Load | 1 | 2022 | 448 | 0.040 |
Why?
| Antibodies, Monoclonal | 1 | 2006 | 1367 | 0.040 |
Why?
| Lipoproteins | 1 | 2020 | 171 | 0.040 |
Why?
| HEK293 Cells | 2 | 2013 | 696 | 0.040 |
Why?
| Carbon | 1 | 2020 | 204 | 0.040 |
Why?
| MAP Kinase Signaling System | 1 | 2021 | 313 | 0.040 |
Why?
| T-Lymphocytes | 1 | 2007 | 1933 | 0.040 |
Why?
| Piperazines | 1 | 2021 | 341 | 0.040 |
Why?
| Neoplasm Transplantation | 1 | 2019 | 256 | 0.040 |
Why?
| Microglia | 1 | 2020 | 232 | 0.040 |
Why?
| Genomics | 2 | 2014 | 717 | 0.040 |
Why?
| Triglycerides | 1 | 2020 | 527 | 0.040 |
Why?
| Amyloid beta-Peptides | 1 | 2020 | 211 | 0.040 |
Why?
| Tandem Mass Spectrometry | 2 | 2013 | 523 | 0.040 |
Why?
| Male | 7 | 2024 | 63501 | 0.040 |
Why?
| Female | 8 | 2022 | 68543 | 0.040 |
Why?
| Drug Resistance, Multiple | 1 | 2017 | 25 | 0.030 |
Why?
| Dimerization | 1 | 2017 | 191 | 0.030 |
Why?
| Child | 1 | 2016 | 20773 | 0.030 |
Why?
| Models, Biological | 2 | 2014 | 1722 | 0.030 |
Why?
| Rats, Sprague-Dawley | 2 | 2012 | 2396 | 0.030 |
Why?
| Nitroglycerin | 1 | 2014 | 17 | 0.030 |
Why?
| Circular Dichroism | 1 | 2015 | 147 | 0.030 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 2014 | 84 | 0.030 |
Why?
| Unfolded Protein Response | 1 | 2014 | 53 | 0.030 |
Why?
| Calorimetry | 1 | 2014 | 66 | 0.030 |
Why?
| Adult | 1 | 2016 | 35495 | 0.030 |
Why?
| Magnesium | 1 | 2014 | 153 | 0.030 |
Why?
| Phenotype | 1 | 2022 | 3074 | 0.030 |
Why?
| Sequence Homology, Amino Acid | 1 | 2014 | 372 | 0.030 |
Why?
| Lung | 2 | 2022 | 3926 | 0.030 |
Why?
| Cell Cycle Checkpoints | 1 | 2013 | 95 | 0.030 |
Why?
| Retinoid X Receptors | 1 | 2013 | 41 | 0.030 |
Why?
| Caco-2 Cells | 1 | 2013 | 75 | 0.030 |
Why?
| RNA Splice Sites | 1 | 2013 | 44 | 0.030 |
Why?
| Macrophages | 1 | 2020 | 1484 | 0.030 |
Why?
| Hyperuricemia | 1 | 2013 | 44 | 0.030 |
Why?
| Biotinylation | 1 | 2012 | 29 | 0.030 |
Why?
| Kainic Acid | 1 | 2012 | 34 | 0.020 |
Why?
| Synaptosomes | 1 | 2012 | 30 | 0.020 |
Why?
| Anilino Naphthalenesulfonates | 1 | 2012 | 10 | 0.020 |
Why?
| Excitatory Amino Acid Agonists | 1 | 2012 | 40 | 0.020 |
Why?
| Fishes | 1 | 2013 | 94 | 0.020 |
Why?
| Anura | 1 | 2012 | 38 | 0.020 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 257 | 0.020 |
Why?
| Telomere | 1 | 2015 | 232 | 0.020 |
Why?
| Electron Transport Complex IV | 1 | 2012 | 57 | 0.020 |
Why?
| Methyltransferases | 1 | 2013 | 70 | 0.020 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 110 | 0.020 |
Why?
| Cysteine Proteinase Inhibitors | 1 | 2012 | 50 | 0.020 |
Why?
| ATP-Binding Cassette Transporters | 1 | 2013 | 133 | 0.020 |
Why?
| Molecular Weight | 1 | 2012 | 328 | 0.020 |
Why?
| Ubiquitination | 1 | 2012 | 98 | 0.020 |
Why?
| Immunoprecipitation | 1 | 2012 | 157 | 0.020 |
Why?
| Sulfonamides | 1 | 2015 | 495 | 0.020 |
Why?
| Rats | 2 | 2012 | 5482 | 0.020 |
Why?
| Gene Knockout Techniques | 1 | 2012 | 109 | 0.020 |
Why?
| Inhibitory Concentration 50 | 1 | 2011 | 86 | 0.020 |
Why?
| Endoplasmic Reticulum | 1 | 2014 | 261 | 0.020 |
Why?
| Amination | 1 | 2011 | 2 | 0.020 |
Why?
| Oxidants | 1 | 2012 | 109 | 0.020 |
Why?
| Genome, Human | 1 | 2014 | 392 | 0.020 |
Why?
| Alkylation | 1 | 2011 | 24 | 0.020 |
Why?
| Nucleic Acid Conformation | 1 | 2015 | 706 | 0.020 |
Why?
| Embryo, Mammalian | 1 | 2012 | 224 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2015 | 1691 | 0.020 |
Why?
| Protein Subunits | 1 | 2012 | 234 | 0.020 |
Why?
| Lipid Droplets | 1 | 2011 | 21 | 0.020 |
Why?
| Chromatography, Liquid | 1 | 2013 | 424 | 0.020 |
Why?
| Binding, Competitive | 1 | 2011 | 206 | 0.020 |
Why?
| Histone Deacetylase Inhibitors | 1 | 2013 | 209 | 0.020 |
Why?
| Metabolic Networks and Pathways | 1 | 2012 | 178 | 0.020 |
Why?
| Cloning, Molecular | 1 | 2012 | 525 | 0.020 |
Why?
| DNA Primers | 1 | 2012 | 510 | 0.020 |
Why?
| Glycogen Synthase Kinase 3 beta | 1 | 2011 | 68 | 0.020 |
Why?
| Ligands | 1 | 2013 | 621 | 0.020 |
Why?
| Glycogen Synthase Kinase 3 | 1 | 2011 | 79 | 0.020 |
Why?
| Membranes, Artificial | 1 | 2011 | 70 | 0.020 |
Why?
| Lipid Peroxidation | 1 | 2011 | 151 | 0.020 |
Why?
| Mammary Glands, Human | 1 | 2011 | 64 | 0.020 |
Why?
| NAD | 1 | 2011 | 75 | 0.020 |
Why?
| Mammals | 1 | 2012 | 272 | 0.020 |
Why?
| Acetylation | 1 | 2011 | 244 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 947 | 0.020 |
Why?
| Protein Structure, Secondary | 1 | 2011 | 340 | 0.020 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 360 | 0.020 |
Why?
| Transfection | 1 | 2012 | 915 | 0.020 |
Why?
| In Vitro Techniques | 1 | 2011 | 1085 | 0.020 |
Why?
| Analysis of Variance | 1 | 2012 | 1288 | 0.020 |
Why?
| DNA Breaks, Single-Stranded | 1 | 2009 | 5 | 0.020 |
Why?
| Phylogeny | 1 | 2012 | 849 | 0.020 |
Why?
| Evolution, Molecular | 1 | 2012 | 464 | 0.020 |
Why?
| Animal Feed | 1 | 2008 | 50 | 0.020 |
Why?
| NADPH-Ferrihemoprotein Reductase | 1 | 2008 | 10 | 0.020 |
Why?
| Hypoxia | 1 | 2015 | 1084 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2013 | 1204 | 0.020 |
Why?
| Microsomes, Liver | 1 | 2008 | 87 | 0.020 |
Why?
| Caspases | 1 | 2009 | 245 | 0.020 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 1344 | 0.020 |
Why?
| Oxygen | 1 | 2012 | 915 | 0.020 |
Why?
| Liver Neoplasms | 1 | 2012 | 640 | 0.020 |
Why?
| Tetrazolium Salts | 1 | 2006 | 17 | 0.020 |
Why?
| Transcription Factor AP-1 | 1 | 2007 | 88 | 0.020 |
Why?
| NFATC Transcription Factors | 1 | 2007 | 84 | 0.020 |
Why?
| Indicators and Reagents | 1 | 2006 | 109 | 0.020 |
Why?
| Cell Respiration | 1 | 2006 | 98 | 0.020 |
Why?
| Deoxyuridine | 1 | 2006 | 6 | 0.020 |
Why?
| Thiazoles | 1 | 2006 | 117 | 0.020 |
Why?
| Mitochondria | 1 | 2012 | 877 | 0.020 |
Why?
| Cysteine | 1 | 2007 | 195 | 0.020 |
Why?
| Smoke | 1 | 2007 | 139 | 0.020 |
Why?
| Drug Carriers | 1 | 2006 | 119 | 0.020 |
Why?
| Superoxides | 1 | 2006 | 201 | 0.020 |
Why?
| Proteomics | 1 | 2012 | 1054 | 0.020 |
Why?
| Drug Interactions | 1 | 2006 | 393 | 0.010 |
Why?
| Colonic Neoplasms | 1 | 2006 | 242 | 0.010 |
Why?
| Drug Delivery Systems | 1 | 2006 | 333 | 0.010 |
Why?
| Oxygen Consumption | 1 | 2006 | 672 | 0.010 |
Why?
| Respiratory Tract Infections | 1 | 2007 | 376 | 0.010 |
Why?
| Time Factors | 1 | 2012 | 6543 | 0.010 |
Why?
| Liver | 1 | 2008 | 1839 | 0.010 |
Why?
| Aged | 1 | 2019 | 22032 | 0.010 |
Why?
| Child, Preschool | 1 | 2014 | 10456 | 0.010 |
Why?
| Cytokines | 1 | 2007 | 2013 | 0.010 |
Why?
| Middle Aged | 1 | 2019 | 31087 | 0.010 |
Why?
|
|
Reigan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|